589 related articles for article (PubMed ID: 17107947)
21. Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones.
Hwahng SH; Ki SH; Bae EJ; Kim HE; Kim SG
Hepatology; 2009 Jun; 49(6):1913-25. PubMed ID: 19378344
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction.
Jin SH; Yang JH; Shin BY; Seo K; Shin SM; Cho IJ; Ki SH
Toxicol Appl Pharmacol; 2013 Aug; 271(1):95-105. PubMed ID: 23651738
[TBL] [Abstract][Full Text] [Related]
23. Thyroid hormone receptor beta (TRbeta) and liver X receptor (LXR) regulate carbohydrate-response element-binding protein (ChREBP) expression in a tissue-selective manner.
Gauthier K; Billon C; Bissler M; Beylot M; Lobaccaro JM; Vanacker JM; Samarut J
J Biol Chem; 2010 Sep; 285(36):28156-63. PubMed ID: 20615868
[TBL] [Abstract][Full Text] [Related]
24. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.
Na TY; Shin YK; Roh KJ; Kang SA; Hong I; Oh SJ; Seong JK; Park CK; Choi YL; Lee MO
Hepatology; 2009 Apr; 49(4):1122-31. PubMed ID: 19105208
[TBL] [Abstract][Full Text] [Related]
25. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor.
Inaba T; Matsuda M; Shimamura M; Takei N; Terasaka N; Ando Y; Yasumo H; Koishi R; Makishima M; Shimomura I
J Biol Chem; 2003 Jun; 278(24):21344-51. PubMed ID: 12672813
[TBL] [Abstract][Full Text] [Related]
26. Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.
Green CD; Jump DB; Olson LK
Endocrinology; 2009 Jun; 150(6):2637-45. PubMed ID: 19228891
[TBL] [Abstract][Full Text] [Related]
27. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.
Liang G; Yang J; Horton JD; Hammer RE; Goldstein JL; Brown MS
J Biol Chem; 2002 Mar; 277(11):9520-8. PubMed ID: 11782483
[TBL] [Abstract][Full Text] [Related]
28. Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.
Lin YN; Wang CCN; Chang HY; Chu FY; Hsu YA; Cheng WK; Ma WC; Chen CJ; Wan L; Lim YP
J Agric Food Chem; 2018 Nov; 66(44):11647-11662. PubMed ID: 30359008
[TBL] [Abstract][Full Text] [Related]
29. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements.
Yoshikawa T; Shimano H; Yahagi N; Ide T; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Tomita S; Okazaki H; Tamura Y; Iizuka Y; Ohashi K; Takahashi A; Sone H; Osuga Ji J; Gotoda T; Ishibashi S; Yamada N
J Biol Chem; 2002 Jan; 277(3):1705-11. PubMed ID: 11694526
[TBL] [Abstract][Full Text] [Related]
30. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
[TBL] [Abstract][Full Text] [Related]
31. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
[TBL] [Abstract][Full Text] [Related]
32. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
Basciano H; Miller A; Baker C; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
[TBL] [Abstract][Full Text] [Related]
33. Effects of fish oil feeding and fasting on LXRalpha/RXRalpha binding to LXRE in the SREBP-1c promoter in mouse liver.
Nakatani T; Katsumata A; Miura S; Kamei Y; Ezaki O
Biochim Biophys Acta; 2005 Sep; 1736(1):77-86. PubMed ID: 16112614
[TBL] [Abstract][Full Text] [Related]
34. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation.
Chu K; Miyazaki M; Man WC; Ntambi JM
Mol Cell Biol; 2006 Sep; 26(18):6786-98. PubMed ID: 16943421
[TBL] [Abstract][Full Text] [Related]
35. Induction of SREBP-1c mRNA by differentiation and LXR ligand in human keratinocytes.
Yokoyama A; Makishima M; Choi M; Cho Y; Nishida S; Hashimoto Y; Terui T
J Invest Dermatol; 2009 Jun; 129(6):1395-401. PubMed ID: 19242521
[TBL] [Abstract][Full Text] [Related]
36. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo.
Beyer TP; Schmidt RJ; Foxworthy P; Zhang Y; Dai J; Bensch WR; Kauffman RF; Gao H; Ryan TP; Jiang XC; Karathanasis SK; Eacho PI; Cao G
J Pharmacol Exp Ther; 2004 Jun; 309(3):861-8. PubMed ID: 14960661
[TBL] [Abstract][Full Text] [Related]
37. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.
Kay HY; Kim WD; Hwang SJ; Choi HS; Gilroy RK; Wan YJ; Kim SG
Antioxid Redox Signal; 2011 Oct; 15(8):2135-46. PubMed ID: 21504366
[TBL] [Abstract][Full Text] [Related]
38. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.
Proctor G; Jiang T; Iwahashi M; Wang Z; Li J; Levi M
Diabetes; 2006 Sep; 55(9):2502-9. PubMed ID: 16936198
[TBL] [Abstract][Full Text] [Related]
39. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.
Dentin R; Pégorier JP; Benhamed F; Foufelle F; Ferré P; Fauveau V; Magnuson MA; Girard J; Postic C
J Biol Chem; 2004 May; 279(19):20314-26. PubMed ID: 14985368
[TBL] [Abstract][Full Text] [Related]
40. The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c.
Jakel H; Nowak M; Moitrot E; Dehondt H; Hum DW; Pennacchio LA; Fruchart-Najib J; Fruchart JC
J Biol Chem; 2004 Oct; 279(44):45462-9. PubMed ID: 15317819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
